Patents by Inventor Andrew Barszczyk

Andrew Barszczyk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230284940
    Abstract: Provided are systems and methods for determination of a concentration of one or more blood biomarkers of a human subject. The method including: determining, using a first machine learning model trained with a hemoglobin concentration (HC) changes training set, bit values from a set of bitplanes in a captured image sequence that represent the HC changes of the subject, the set of bitplanes being those that are determined to approximately maximize a signal-to-noise ratio (SNR), the HC changes training set including bit values from each bitplane of images captured from a set of subjects for which HC changes are known; determining, using a second machine learning model trained using a blood biomarkers training set, concentration of one or more blood biomarkers, the blood biomarkers training set including previously determined HC change signals from other subjects and one or more blood panels from those subjects as ground truth data.
    Type: Application
    Filed: May 18, 2023
    Publication date: September 14, 2023
    Inventors: Kang LEE, Andrew Barszczyk, Sijia Wu, Yousef Yasin, Winston De Armas, Alan Ding
  • Patent number: 11690543
    Abstract: Provided are systems and methods for determination of a concentration of one or more blood biomarkers of a human subject. The method including: determining, using a first machine learning model trained with a hemoglobin concentration (HC) changes training set, bit values from a set of bitplanes in a captured image sequence that represent the HC changes of the subject, the set of bitplanes being those that are determined to approximately maximize a signal-to-noise ratio (SNR), the HC changes training set including bit values from each bitplane of images captured from a set of subjects for which HC changes are known; determining, using a second machine learning model trained using a blood biomarkers training set, concentration of one or more blood biomarkers, the blood biomarkers training set including previously determined HC change signals from other subjects and one or more blood panels from those subjects as ground truth data.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: July 4, 2023
    Assignee: NURALOGIX CORPORATION
    Inventors: Kang Lee, Andrew Barszczyk, Sijia Wu, Yousef Yasin, Winston De Armas, Alan Ding
  • Publication number: 20220265171
    Abstract: Provided are systems and methods for determination of a concentration of one or more blood biomarkers of a human subject. The method including: determining, using a first machine learning model trained with a hemoglobin concentration (HC) changes training set, bit values from a set of bitplanes in a captured image sequence that represent the HC changes of the subject, the set of bitplanes being those that are determined to approximately maximize a signal-to-noise ratio (SNR), the HC changes training set including bit values from each bitplane of images captured from a set of subjects for which HC changes are known; determining, using a second machine learning model trained using a blood biomarkers training set, concentration of one or more blood biomarkers, the blood biomarkers training set including previously determined HC change signals from other subjects and one or more blood panels from those subjects as ground truth data.
    Type: Application
    Filed: June 30, 2020
    Publication date: August 25, 2022
    Inventors: Kang LEE, Andrew BARSZCZYK, Sijia WU, Yousef YASIN, Winston DE ARMAS, Alan DING
  • Patent number: 9382301
    Abstract: A novel isolated protein, referred to herein as “caltubin”, is provided. Caltubin promotes axonal regeneration, and prevents or at least reduces axonal retraction in neurons.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: July 5, 2016
    Assignee: University of Toronto
    Inventors: Zhong-Ping Feng, Nasrin Nejatbakhsh, Ronald E. Van Kesteren, August B. Smit, Hong-Shou Sun, Andrew Barszczyk
  • Publication number: 20140329757
    Abstract: A novel isolated protein, referred to herein as “caltubin”, is provided. Caltubin promotes axonal regeneration, and prevents or at least reduces axonal retraction in neurons.
    Type: Application
    Filed: October 12, 2012
    Publication date: November 6, 2014
    Applicant: University of Toronto
    Inventors: Zhong-Ping Feng, Nasrin Najatbakhsh, Ronald E. Van Kasteren, August B. Smit, Hong-Shou Sun, Andrew Barszczyk